跳轉至內容
Merck
HomeWebinarsEfficient Scale-up & Manufacture of mAbs for Diagnostics

Efficient Scale-up & Manufacture of mAbs for Diagnostics



WEBINAR

Monoclonal antibodies (mAbs) are used extensively in the diagnostics industry, where their superior selectivity and binding greatly increases the robustness of such tests.  This webinar describes an approach for efficient scale-up of a bench-scale mAb process.

Topics to be covered include:

  • Commercial-scale approach to mAb production
  • Considerations for scale-up
  • Large-scale production technologies

This in-depth webinar will be valuable for all of those involved in bringing diagnostic assays to market including:

  • Diagnostic test developers
  • In vitro diagnostics manufacturers
  • In vitro diagnostics QA/QC personnel

Speaker

Paul Beckett

Paul Beckett

Merck

Senior Manager, Downstream Technologies, BioContinuum™ Platform

Paul holds a B.S. in biochemistry from Imperial College London and has an M.S. and Ph.D. in biochemical engineering from University College London. Paul has worked in the pharmaceutical industry for 20 years and has held a number of roles in this capacity, including managing bioprocesses for early phase clinical material, CMC regulatory affairs consultancy, and downstream bioprocessing technology consultancy. Currently, Paul is a senior manager responsible for the DSP strategy for the BioContinuum™ next-generation processing platform.

登入以繼續

若要繼續閱讀,請登入或建立帳戶。

還沒有帳戶?